Eventide Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Eventide Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-670,020	Closed	-$71.9M	–	163
2023 Q1	$71.9M	Sell	670,020 -362,918	-35%	-$41.8M	1.32%	22
2022 Q4	$114M	Sell	1,032,938 -1,636,317	-61%	-$106M	2.24%	7
2022 Q3	$158M	Sell	2,669,255 -563,445	-17%	-$25.8M	3.1%	1
2022 Q2	$91.3M	Hold	3,232,700	–	–	1.95%	14
2022 Q1	$122M	Sell	3,232,700 -509,807	-14%	-$20.2M	1.91%	15
2021 Q4	$145M	Buy	3,742,507 +28,475	+0.8%	+$891K	1.85%	13
2021 Q3	$85.1M	Hold	3,714,032	–	–	1.12%	34
2021 Q2	$88.2M	Hold	3,714,032	–	–	1.18%	32
2021 Q1	$65.6M	Buy	+3,714,032	New	+$76.7M	0.97%	39

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Eventide Asset Management's RXDX Position: Q2 2023 in Review

Eventide Asset Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 670,020 shares — an estimated $71.9M sold.

Eventide Asset Management first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $158M in Q3 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Eventide Asset Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Eventide Asset Management sold 670,020 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $71.9M.
Eventide Asset Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Eventide Asset Management's Prometheus Biosciences, Inc. Common Stock position peaked at $158M in Q3 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Eventide Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.